Related Experiment Video
Updated: Feb 16, 2026

09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
19.9K
Autoimmune Hepatitis: A Risk Factor for Cholangiocarcinoma
Rajat Garg1, Uqba Khan2, Ahmed AlRajjal3
1Department of Internal Medicine, St. John Hospital and Medical Center, Detroit, Michigan, USA.
Case Reports in Gastroenterology
|December 29, 2017
Summary
Cholangiocarcinoma (bile duct cancer) is a rare but aggressive cancer. This case highlights the link between autoimmune hepatitis and perihilar cholangiocarcinoma, emphasizing close patient monitoring.
Area of Science:
- Hepatology and Oncology
- Gastroenterology
- Cancer Research
Background:
- Cholangiocarcinoma (CCA) is an aggressive bile duct cancer, accounting for 3% of GI malignancies.
- CCA incidence is increasing, with known risk factors including chronic liver diseases and genetic disorders.
- Autoimmune hepatitis is a newly recognized potential risk factor for CCA development.
Observation:
- A case of perihilar cholangiocarcinoma (CCA) was observed in a patient with autoimmune hepatitis.
- This presentation prompted a review of the existing literature on this association.
- The case underscores the importance of vigilance for CCA in patients with autoimmune hepatitis.
Findings:
- The study identified a correlation between autoimmune hepatitis and the development of perihilar cholangiocarcinoma.
- Literature review supports the association between autoimmune liver diseases and biliary tract cancers.
- Early detection and management of autoimmune hepatitis may play a role in mitigating CCA risk.
Implications:
- This case emphasizes the need for heightened awareness and surveillance for cholangiocarcinoma in patients diagnosed with autoimmune hepatitis.
- Early diagnosis and treatment of autoimmune hepatitis are crucial for potentially preventing CCA.
- Further research is warranted to elucidate the mechanisms linking autoimmune hepatitis and CCA development.
Related Concept Videos
Factors Affecting the Risk of Infection
13.9K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.9K
Drug Toxicity: Risk factors
18
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
18
Hepatic Drug Excretion: Influencing Factors
626
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
626
Relative Risk
2.2K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.2K
Autoimmune Disorders
1.9K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.9K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
282
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
282

